Suppr超能文献

结核分枝杆菌热休克融合蛋白增强B淋巴细胞的I类主要组织相容性复合体交叉处理及呈递。

Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes.

作者信息

Tobian Aaron A R, Harding Clifford V, Canaday David H

机构信息

Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

J Immunol. 2005 May 1;174(9):5209-14. doi: 10.4049/jimmunol.174.9.5209.

Abstract

Exogenous heat shock protein (HSP):peptide complexes are processed for cross-presentation of HSP-chaperoned peptides on class I MHC (MHC-I) molecules. Fusion proteins containing HSP and Ag sequences facilitate MHC-I cross-presentation of linked antigenic epitopes. Processing of HSP-associated Ag has been attributed to dendritic cells and macrophages. We now provide the first evidence to show processing of HSP-associated Ag for MHC-I cross-presentation by B lymphocytes. Fusion of OVA sequence (rOVA, containing OVA(230-359) sequence) to Mycobacterium tuberculosis HSP70 greatly enhanced rOVA processing and MHC-I cross-presentation of OVA(257-264):K(b) complexes by B cells. Enhanced processing was dependent on linkage of rOVA sequence to HSP70. M. tuberculosis HSP70-OVA fusion protein enhanced cross-processing by a CD91-dependent process that was independent of TLR4 and MyD88. The enhancement occurred through a post-Golgi, proteasome-independent mechanism. These results indicate that HSPs enhance delivery and cross-processing of HSP-linked Ag by B cells, which could provide a novel contribution to the generation of CD8(+) T cell responses. HSP fusion proteins have potential advantages for use in vaccines to enhance priming of CD8(+) T cell responses.

摘要

外源性热休克蛋白(HSP):肽复合物经处理后可将HSP伴侣肽交叉呈递于I类主要组织相容性复合体(MHC-I)分子上。含有HSP和抗原序列的融合蛋白有助于将连接的抗原表位进行MHC-I交叉呈递。HSP相关抗原的处理归因于树突状细胞和巨噬细胞。我们现在提供首个证据,表明B淋巴细胞可对HSP相关抗原进行处理以用于MHC-I交叉呈递。将卵清蛋白序列(rOVA,包含OVA(230 - 359)序列)与结核分枝杆菌HSP70融合,极大地增强了rOVA的处理以及B细胞对OVA(257 - 264):K(b)复合物的MHC-I交叉呈递。增强的处理依赖于rOVA序列与HSP70的连接。结核分枝杆菌HSP70 - OVA融合蛋白通过一种依赖CD91的过程增强交叉处理,该过程独立于Toll样受体4(TLR4)和髓样分化因子88(MyD88)。这种增强通过一种高尔基体后、不依赖蛋白酶体的机制发生。这些结果表明,HSP可增强B细胞对HSP连接抗原的递送和交叉处理,这可能为CD8(+) T细胞反应的产生提供新的作用。HSP融合蛋白在用于增强CD8(+) T细胞反应启动的疫苗方面具有潜在优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验